INBX Competitors & Alternatives
Compare Inhibrx Biosciences, Inc. with similar stocks in the same industry
Biotechnology
INBX
Main Stock$90.61
Tradestie Score
53
Market Cap
$492.21M
Revenue Growth
-1.0%
Analyst Upside
+194.3%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RCUS
Arcus Biosciences, Inc.
|
$18.67
|
$1.43B | - | 64 | Compare |
|
JANX
Janux Therapeutics, Inc. Common Stock
|
$12.04
|
$1.42B | - | 46 | Compare |
|
SNDX
Syndax Pharmaceuticals, Inc.
|
$9.49
|
$1.35B | - | 55 | Compare |
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$25.96
|
$1.32B | - | 58 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$15.83
|
$1.29B | - | 39 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$27.21
|
$1.29B | - | 44 | Compare |
|
ARDX
Ardelyx, Inc.
|
$3.01
|
$1.29B | - | 57 | Compare |
|
ZYME
Zymeworks Inc.
|
$31.46
|
$1.28B | - | 41 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$4.27
|
$1.27B | - | 60 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 54 | Compare |
More INBX Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 2836)
218 stocks in this industry